News
Rebrain SAS's Optimmri platform received European Medical Device Regulation CE mark certification to enable surgeons to ...
Even before the Trump administration’s executive order wiping out the concept of diversity, equity and inclusion, the statistics on female representation in the biotech industry painted a story of ...
The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results